# Study to Assess the Effects of Esketamine on Safety of On-road Driving in Healthy Participants

> **NCT02228239** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 26 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Esketamine
- **DRUG:** Mirtazapine
- **DRUG:** Placebo (Matched to Esketamine)
- **DRUG:** Placebo (Matched to Mirtazapine)

## Key facts

- **NCT ID:** NCT02228239
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02228239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02228239, "Study to Assess the Effects of Esketamine on Safety of On-road Driving in Healthy Participants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02228239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*